March 16, 2013 Schedule

Session 1: Human pancreas development (8:00 am to 10:00 am)
Moderator
Andrew Stewart, M.D. (Mount Sinai School of Medicine, New York, NY)

 

A careful look at human endocrine pancreas development: Part 1
Marcela Brissova, Ph.D. (Vanderbilt University, Nashville, TN)

 

A careful look at human endocrine pancreas development: Part 2
Philip DiIorio, Ph.D. (University of Massachusetts School of Medicine, Worcester, MA)

 

Endocrine pancreas development in the non-human primate pancreas
Lynley Pound, Ph.D. (Oregon National Primate Research Center, Beaverton, OR)

Development of authentic human beta cell lines
Philippe Ravassard,Ph.D. (ICM-INSERM, Paris, France)

Debate: The beta-cell will be preserved with currently available therapy in type 2 diabetes(10:15 am to 11:15 am)
Moderator
Robert Vigersky, M.D. (Walter Reed National Military Medical Center, Washington, DC)

Position 1
Philip Raskin, M.D. (UT Southwestern Medical Center, Dallas, TX)

Position 2
John Leahy, M.D. (University of Vermont, Colchester, VT)

 

Session 2: Clinical controversies in diabetes care (11:30 am to 1:30 pm)
Moderator
Fouad Kandeel, M.D., Ph.D. (City of Hope, Duarte, CA)

 

Glycemic control diabetes complications: Implications for care in the post-ACCORD era
David Kendall, M.D. (Lilly Diabetes, Minneapolis, MN)

DCCT/EDIC Research Group update
John M. Lachin, Sc.D. (The George Washington University, Rockville, MD)

Use of bariatric surgery to cure diabetes
Philip Schauer, M.D. (Cleveland Clinic, Cleveland, OH)

Glycemic variability
Robert Vigersky, M.D.(Walter Reed National Military Medical Center, Washington, DC)